Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Withdrawn 1 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 33 Brain Neoplasms 21 Carcinoma, Non-Small-Cell Lung 19 Neoplasm Metastasis 17 Lung Neoplasms 15 Carcinoma, Hepatocellular 13 Breast Neoplasms 10 Pancreatic Neoplasms 9 Melanoma 9 Carcinoma, Renal Cell 9 Neoplasms 6 Colorectal Neoplasms 6 Triple Negative Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Spinal Cord Neoplasms 3 Small Cell Lung Carcinoma 3 Prostate Cancer Metastatic 3 Nasopharyngeal Carcinoma 3 Kidney Neoplasms 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Unresectable Locally Recurrent Rectal Cancer 2 Sarcoma 2 Radiation Injuries 2 Osteosarcoma 2 Oligometastatic Prostate Cancer 2 Neuroma, Acoustic 2 Neoplasms by Site 2 Klatskin Tumor 2 Head and Neck Neoplasms 2

Interventions

Bevacizumab 40 Paclitaxel 35 Carboplatin 28 pembrolizumab 21 Cyclophosphamide 15 Specimen Handling 14 Cisplatin 13 olaparib 11 Blood Specimen Collection 11 niraparib 10 fludarabine 10 Magnetic Resonance Spectroscopy 9 Drug Therapy 9 liposomal doxorubicin 8 Topotecan 8 Taxes 8 Gemcitabine 8 Biopsy 8 Fulvestrant 7 Doxorubicin 6 cemiplimab 5 abemaciclib 5 Surveys and Questionnaires 5 Standard of Care 5 Injections 5 Fluorouracil 5 Cytoreduction Surgical Procedures 5 trastuzumab deruxtecan 4 mirvetuximab soravtansine 4 aldesleukin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ovarian Neoplasms × Radiosurgery × Clear all

NCT05990192 2025-04-22

SOPRANO

Institute of Cancer Research, United Kingdom

Phase 2 Recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡